Personensuche
X
?
1
Consort flow diagram. ART, antiretroviral therapy; PEBRA, P..:
Mathebe Kopo (7235687) ; Thabo Ishmael Lejone (7321058) ; Nadine Tschumi (12232941)...
https://figshare.com/articles/figure/Consort_flow_diagram_ART_antiretroviral_therapy_PEBRA_Peer_Educator-Based_Refill_of_ART_VL_viral_load_/21807634. , 2023
https://figshare.com/articles/figure/Consort_flow_diagram_ART_antiretroviral_therapy_PEBRA_Peer_Educator-Based_Refill_of_ART_VL_viral_load_/21807634. , 2023
?
2
Sensitivity analyses 2 and 3 on primary endpoint:
Mathebe Kopo (7235687) ; Thabo Ishmael Lejone (7321058) ; Nadine Tschumi (12232941)...
https://figshare.com/articles/journal_contribution/Sensitivity_analyses_2_and_3_on_primary_endpoint_/21807625. , 2023
https://figshare.com/articles/journal_contribution/Sensitivity_analyses_2_and_3_on_primary_endpoint_/21807625. , 2023
?
3
CONSORT 2010 checklist for cluster-randomized trials:
Mathebe Kopo (7235687) ; Thabo Ishmael Lejone (7321058) ; Nadine Tschumi (12232941)...
https://figshare.com/articles/journal_contribution/CONSORT_2010_checklist_for_cluster-randomized_trials_/21807616. , 2023
https://figshare.com/articles/journal_contribution/CONSORT_2010_checklist_for_cluster-randomized_trials_/21807616. , 2023
?
4
Primary outcome: Effect modification:
Mathebe Kopo (7235687) ; Thabo Ishmael Lejone (7321058) ; Nadine Tschumi (12232941)...
https://figshare.com/articles/journal_contribution/Primary_outcome_Effect_modification_/21807628. , 2023
https://figshare.com/articles/journal_contribution/Primary_outcome_Effect_modification_/21807628. , 2023
?
5
Baseline characteristics of study participants:
Mathebe Kopo (7235687) ; Thabo Ishmael Lejone (7321058) ; Nadine Tschumi (12232941)...
https://figshare.com/articles/dataset/Baseline_characteristics_of_study_participants_/21807637. , 2023
https://figshare.com/articles/dataset/Baseline_characteristics_of_study_participants_/21807637. , 2023
?
6
Details about each PEBRA intervention component option:
Mathebe Kopo (7235687) ; Thabo Ishmael Lejone (7321058) ; Nadine Tschumi (12232941)...
https://figshare.com/articles/journal_contribution/Details_about_each_PEBRA_intervention_component_option_/21807619. , 2023
https://figshare.com/articles/journal_contribution/Details_about_each_PEBRA_intervention_component_option_/21807619. , 2023
?
7
Primary and secondary endpoints:
Mathebe Kopo (7235687) ; Thabo Ishmael Lejone (7321058) ; Nadine Tschumi (12232941)...
https://figshare.com/articles/dataset/Primary_and_secondary_endpoints_/21807640. , 2023
https://figshare.com/articles/dataset/Primary_and_secondary_endpoints_/21807640. , 2023
?
8
Primary analysis model with fixed covariables and prespecif..:
Mathebe Kopo (7235687) ; Thabo Ishmael Lejone (7321058) ; Nadine Tschumi (12232941)...
https://figshare.com/articles/journal_contribution/Primary_analysis_model_with_fixed_covariables_and_prespecified_sensitivity_analysis_with_adjustment_for_baseline_VL_/21807622. , 2023
https://figshare.com/articles/journal_contribution/Primary_analysis_model_with_fixed_covariables_and_prespecified_sensitivity_analysis_with_adjustment_for_baseline_VL_/21807622. , 2023
?
9
Description of the PEBRA model and clusters. ART, antiretro..:
Mathebe Kopo (7235687) ; Thabo Ishmael Lejone (7321058) ; Nadine Tschumi (12232941)...
https://figshare.com/articles/figure/Description_of_the_PEBRA_model_and_clusters_ART_antiretroviral_therapy_PEBRA_Peer_Educator-Based_Refill_of_ART_/21807631. , 2023
https://figshare.com/articles/figure/Description_of_the_PEBRA_model_and_clusters_ART_antiretroviral_therapy_PEBRA_Peer_Educator-Based_Refill_of_ART_/21807631. , 2023
?
10
Flow of intervention participants:
Alain Amstutz (3161721) ; Thabo Ishmael Lejone (7321058) ; Lefu Khesa (7235672)...
https://figshare.com/articles/journal_contribution/Flow_of_intervention_participants_/16849713. , 2021
https://figshare.com/articles/journal_contribution/Flow_of_intervention_participants_/16849713. , 2021
?
11
Primary outcome: Effect modification and subgroup analyses:
Alain Amstutz (3161721) ; Thabo Ishmael Lejone (7321058) ; Lefu Khesa (7235672)...
https://figshare.com/articles/journal_contribution/Primary_outcome_Effect_modification_and_subgroup_analyses_/16849722. , 2021
https://figshare.com/articles/journal_contribution/Primary_outcome_Effect_modification_and_subgroup_analyses_/16849722. , 2021
?
12
Twelve-month tracing outcomes of participants out of care i..:
Alain Amstutz (3161721) ; Thabo Ishmael Lejone (7321058) ; Lefu Khesa (7235672)...
https://figshare.com/articles/dataset/Twelve-month_tracing_outcomes_of_participants_out_of_care_in_both_arms_/16849770. , 2021
https://figshare.com/articles/dataset/Twelve-month_tracing_outcomes_of_participants_out_of_care_in_both_arms_/16849770. , 2021
?
13
Data_Sheet_1_Reaching Absent and Refusing Individuals Durin..:
Alain Amstutz (3161721) ; Lineo Matsela (11040978) ; Thabo Ishmael Lejone (7321058)...
https://figshare.com/articles/dataset/Data_Sheet_1_Reaching_Absent_and_Refusing_Individuals_During_Home-Based_HIV_Testing_Through_Self-Testing_at_What_Cost_docx/14871480. , 2021
https://figshare.com/articles/dataset/Data_Sheet_1_Reaching_Absent_and_Refusing_Individuals_During_Home-Based_HIV_Testing_Through_Self-Testing_at_What_Cost_docx/14871480. , 2021
?
14
Sensitivity analyses on primary endpoints:
Alain Amstutz (3161721) ; Thabo Ishmael Lejone (7321058) ; Lefu Khesa (7235672)...
https://figshare.com/articles/journal_contribution/Sensitivity_analyses_on_primary_endpoints_/16849716. , 2021
https://figshare.com/articles/journal_contribution/Sensitivity_analyses_on_primary_endpoints_/16849716. , 2021
?
15
Primary and secondary endpoints:
Alain Amstutz (3161721) ; Thabo Ishmael Lejone (7321058) ; Lefu Khesa (7235672)...
https://figshare.com/articles/dataset/Primary_and_secondary_endpoints_/16849764. , 2021
https://figshare.com/articles/dataset/Primary_and_secondary_endpoints_/16849764. , 2021